Review of NICE Technology Appraisal Guidance No 88; dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block

Update to defer the review

The Institute conducted a review proposal for this appraisal in October 2006 with the decision that the planned date at which the Institute decides whether sufficient new evidence has emerged for the Appraisal Committee to be asked to undertake a full review appraisal be deferred until December 2009.

The Institute has carried out a search for information relevant to this appraisal, and has found that to the best of its knowledge, no new evidence has been published that would have a material effect on the original guidance.  However, we are aware of a relevant on-going DANPACE trial. Consequently we propose that the review of the original guidance be deferred until results of this trial are available.  At this point the evidence base will again be assessed to ascertain the need for a review of the current guidance.

June 2010